Peptides Derived from Mycobacterium leprae ML1601c Discriminate between Leprosy Patients and Healthy Endemic Controls

Table 1

ML1601c synthetic peptides.

Peptide no.	Amino acid sequence*	Amino acid identity**
11	AHHNAHAAPAFLWSGLVSA	42% (8/19)
12	FLWSGLVSAAVLIADGRGE	52% (10/19)
13	AVLIADGRGEDTYLPIISIY	40% (8/20)
14	DTYLPIISIYLARGNELKPN	10% (2/20)
15	LARGNELKPNPLLSVIYVEH	25% (5/20)
16	PLLSVIYVEHLLVLFYQSVG	35% (7/20)
17	LLVLFYQSVGDHCGFGRYDF	45% (9/20)
18	DHCGFGRYDFGKTMVLACYG	50% (10/20)
19	GKTMVLACYGCVGTRSLLSG	30% (6/20)
20	CVGTRSLLSGRDDDLVTSVP	15% (3/20)
3	RDDDLVTSVPPCGRASVVHRS	0% (0/21)

*Synthetic peptides overlapping ML1601c are shown in single-letter amino acid code.
**Amino acid sequences of ML1601c (M. leprae TN and BR4923) peptides were analyzed using BLAST (http://blast.ncbi.nlm.nih.gov/); amino acids that are identical to the MAP3249 are depicted in bold.